AS there’s currently no cure for dementia, experts recommend focusing on ways to reduce your risk of developing the disease.
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...
As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...
When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...
Researchers from Oxford’s Institute of Population Ageing and the University of Manchester, and Tufts University have found ...
A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate groups and proposed an explanation for how cognitive impairment arises. The ...
A WORD on the tip of the tongue or a forgotten birthday – everyone has occasional memory blanks. While forgetting things ...
First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer ... for later life memory and risk of dementia, according to a new study. The study compared the differences ...
China has launched a national plan to address the rapidly growing prevalence of dementia, which authorities say is becoming ...